Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medicare Negotiation Cycle Two: More Dynamic Offer Process, Better Public Input
Feb 10 2026
•
By
Cathy Kelly
CMS' year two price negotiation post-mortem still gave few details.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from Government Payers